BioLineRx (BLRX) Return on Assets (2011 - 2025)

BioLineRx's Return on Assets history runs 15 years deep, the most recent figure standing at 0.0% for Q4 2025.

• On a quarterly basis, Return on Assets changed 0.0% year-over-year to 0.0% in Q4 2025; TTM through Dec 2025 was 0.0%, a 0.0% change from a year earlier, with the FY2025 full-year figure at 0.0%, changed 0.0% from the prior year.
• Return on Assets climbed to 0.0% in Q4 2025 per BLRX's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q4 2025 and bottomed at 0.01% in Q4 2023.
• The 5-year median for Return on Assets is 0.0% (2022), against an average of 0.0%.
• Across the five-year window, Return on Assets changed 0 bps in 2021 and climbed 1 bps in 2024, its largest moves.
• Year by year, Return on Assets stood at 0.0% in 2021, then decreased by 28 bps to 0.0% in 2022, then tumbled by 123 bps to 0.01% in 2023, then soared by 76 bps to 0.0% in 2024, then jumped by 75 bps to 0.0% in 2025.
• Per Business Quant, the three latest BLRX Return on Assets figures stand at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).